Patent · US Active

Formulations for nonsurgical exogenous crosslink therapy

US8198248B2 · kind B2 · utility

8Cited by
4References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 3, 2008
Grant dateJun 12, 2012
Priority date
Expiry dateOct 24, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P17/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.